Plus Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $1,367 | $1,397 | $1,390 | $1,059 |
Gross Profit | 1,275 | 1,311 | 1,304 | 878 |
EBITDA | -2,327 | -4,337 | 5,272 | -13,461 |
EBIT | -2,384 | -4,423 | 5,151 | -13,642 |
Net Income | -5,713 | -4,423 | 5,151 | -17,401 |
Net Change In Cash | 1,367 | 1,397 | 1,390 | 1,059 |
Free Cash Flow | -6,287 | -2,575 | -5,805 | -6,175 |
Cash | 8,758 | 13,289 | 2,233 | 9,867 |
Basic Shares | 3,112 | 1,074,289 | 209,154 | 14,567 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $5,213 | $5,824 | $4,913 | $224 |
Gross Profit | 4,768 | 4,972 | -4,777 | -488 |
EBITDA | -14,853 | -8,402 | -12,693 | -18,852 |
EBIT | -15,298 | -9,254 | -13,321 | -19,564 |
Net Income | -22,386 | -12,978 | -13,316 | -20,275 |
Net Change In Cash | 5,213 | 5,824 | 4,913 | 224 |
Free Cash Flow | -20,842 | -10,700 | -13,011 | -13,731 |
Cash | 8,758 | 76 | 8,554 | 18,120 |
Basic Shares | 3,112 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.04 |
2025-09-30 | -$0.04 |
2025-06-30 | -$0.006 |
2025-03-31 | -$0.56 |
